🇺🇸 FDA
Pipeline program

VX-445/TEZ/IVA

VX17-445-103

Phase 3 small_molecule completed

Quick answer

VX-445/TEZ/IVA for Cystic Fibrosis is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Cystic Fibrosis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials